UNSPSC 51283410: Sarpicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H27N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O70J1GE4YB, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, (2s-(2alpha,5alpha,6beta))-, methoxymethyl ester but generally known as sarpicillin, which bears US NIH Compound Identifier 65429.

UNSPSC 51283410 Sarpicillin is a Commodity code that nominally names a specific antibiotic pharmaceutical product, but state and local procurement activity under this code shows little alignment with sarpicillin itself. The recent opportunities tagged to this code document pharmaceutical warehouse supply contracts and over-the-counter medical supplies (naloxone and drug deactivation systems) rather than sarpicillin as a pharmaceutical agent. State and local health departments and county public health bodies are the primary issuing parties, typically procuring pharmaceutical inventory through piggyback arrangements on statewide or regional consortia, or through direct competitive bidding for emergency-response and community health supplies. The mix of actual purchases—antibiotics like doxycycline and ciprofloxacin, opioid-reversal agents, and medical waste deactivation systems—suggests the code may be misapplied to broader pharmaceutical procurement categories rather than sarpicillin-specific demand.

Illinois Department of Public Health awarded a piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for doxycycline hyclate and ciprofloxacin, totaling $2,999,999.11 over 12 months with two one-year renewal options, completed in August 2026. Seminole County, Florida issued a competitive IFB (Invitation for Bid) in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, due July 26, 2026. Activity appears concentrated in Florida and Illinois, with contracts structured as either consortium piggyback awards or direct county competitive bids. The code's actual utility for sarpicillin-focused vendors is unclear; recent activity reflects state and county procurement of general pharmaceuticals and emergency-response medical supplies rather than sarpicillin demand.